Revaprazan (trade name Revanex) is a drug that reduces gastric acid secretion which is used for the treatment of gastritis.
[2] It acts as an acid pump antagonist[3] (potassium-competitive acid blocker).
Revaprazan is approved for use in South Korea,[4] but is not approved in Europe or the United States.
This drug article relating to the gastrointestinal system is a stub.
You can help Wikipedia by expanding it.